XML 192 R12.htm IDEA: XBRL DOCUMENT v3.22.4

Basis of Presentation (Tables)

12 Months Ended

Dec. 31, 2022

Basis of Presentation

Schedule of activities of the subsidiary

​

​	​	2 ​	1 ​
Name	Domicile	Ownership and votes 2022	Ownership and votes 2021
Genmab B.V.	Utrecht, the Netherlands	100%	100%
Genmab Holding B.V.	Utrecht, the Netherlands	100%	100%
Genmab US, Inc.	New Jersey, USA	100%	100%
Genmab K.K.	Tokyo, Japan	100%	100%

​

X

- References

No definition available.

+ Details

Name:	gmab_BasisOfPresentationAbstract
Namespace Prefix:	gmab_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph 2
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_2_b_i&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration